These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22966013)

  • 1. CFTR: an ion channel with a transporter-type energy-coupling mechanism.
    Tsai MF
    J Gen Physiol; 2012 Oct; 140(4):343-5. PubMed ID: 22966013
    [No Abstract]   [Full Text] [Related]  

  • 2. On the mechanism of gating defects caused by the R117H mutation in cystic fibrosis transmembrane conductance regulator.
    Yu YC; Sohma Y; Hwang TC
    J Physiol; 2016 Jun; 594(12):3227-44. PubMed ID: 26846474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural mechanisms for defective CFTR gating caused by the Q1412X mutation, a severe Class VI pathogenic mutation in cystic fibrosis.
    Yeh JT; Yu YC; Hwang TC
    J Physiol; 2019 Jan; 597(2):543-560. PubMed ID: 30408177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cystic fibrosis transmembrane conductance regulator phenylalanine 508 side chain in ion channel gating.
    Cui L; Aleksandrov L; Hou YX; Gentzsch M; Chen JH; Riordan JR; Aleksandrov AA
    J Physiol; 2006 Apr; 572(Pt 2):347-58. PubMed ID: 16484308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coupling of ATP hydrolysis with channel gating by purified, reconstituted CFTR.
    Bear CE; Li C; Galley K; Wang Y; Garami E; Ramjeesingh M
    J Bioenerg Biomembr; 1997 Oct; 29(5):465-73. PubMed ID: 9511931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonintegral stoichiometry in CFTR gating revealed by a pore-lining mutation.
    Jih KY; Sohma Y; Hwang TC
    J Gen Physiol; 2012 Oct; 140(4):347-59. PubMed ID: 22966014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial rescue of F508del-cystic fibrosis transmembrane conductance regulator channel gating with modest improvement of protein processing, but not stability, by a dual-acting small molecule.
    Liu J; Bihler H; Farinha CM; Awatade NT; Romão AM; Mercadante D; Cheng Y; Musisi I; Jantarajit W; Wang Y; Cai Z; Amaral MD; Mense M; Sheppard DN
    Br J Pharmacol; 2018 Apr; 175(7):1017-1038. PubMed ID: 29318594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gating of the CFTR channel.
    Moran O
    Cell Mol Life Sci; 2017 Jan; 74(1):85-92. PubMed ID: 27696113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The two ATP binding sites of cystic fibrosis transmembrane conductance regulator (CFTR) play distinct roles in gating kinetics and energetics.
    Zhou Z; Wang X; Liu HY; Zou X; Li M; Hwang TC
    J Gen Physiol; 2006 Oct; 128(4):413-22. PubMed ID: 16966475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence assay for simultaneous quantification of CFTR ion-channel function and plasma membrane proximity.
    Prins S; Langron E; Hastings C; Hill EJ; Stefan AC; Griffin LD; Vergani P
    J Biol Chem; 2020 Dec; 295(49):16529-16544. PubMed ID: 32934006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the F508del mutation on ovine CFTR, a Cl- channel with enhanced conductance and ATP-dependent gating.
    Cai Z; Palmai-Pallag T; Khuituan P; Mutolo MJ; Boinot C; Liu B; Scott-Ward TS; Callebaut I; Harris A; Sheppard DN
    J Physiol; 2015 Jun; 593(11):2427-46. PubMed ID: 25763566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between nucleotide binding and ion channel gating in cystic fibrosis transmembrane conductance regulator.
    Aleksandrov AA; Cui L; Riordan JR
    J Physiol; 2009 Jun; 587(Pt 12):2875-86. PubMed ID: 19403599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of channel gating by AMP-activated protein kinase modulates cystic fibrosis transmembrane conductance regulator activity in lung submucosal cells.
    Hallows KR; McCane JE; Kemp BE; Witters LA; Foskett JK
    J Biol Chem; 2003 Jan; 278(2):998-1004. PubMed ID: 12427743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What we know and what we do not know about cystic fibrosis transmembrane conductance regulator.
    Ma J; Davis PB
    Clin Chest Med; 1998 Sep; 19(3):459-71, v-vi. PubMed ID: 9759549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to investigate the mechanism of action of CFTR modulators.
    Cai Z; Scott-Ward TS; Li H; Schmidt A; Sheppard DN
    J Cyst Fibros; 2004 Aug; 3 Suppl 2():141-7. PubMed ID: 15463947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voltage-dependent gating of the cystic fibrosis transmembrane conductance regulator Cl- channel.
    Cai Z; Scott-Ward TS; Sheppard DN
    J Gen Physiol; 2003 Nov; 122(5):605-20. PubMed ID: 14581585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic fibrosis transmembrane conductance regulator (CFTR) potentiator VX-770 (ivacaftor) opens the defective channel gate of mutant CFTR in a phosphorylation-dependent but ATP-independent manner.
    Eckford PD; Li C; Ramjeesingh M; Bear CE
    J Biol Chem; 2012 Oct; 287(44):36639-49. PubMed ID: 22942289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altering intracellular pH reveals the kinetic basis of intraburst gating in the CFTR Cl
    Chen JH; Xu W; Sheppard DN
    J Physiol; 2017 Feb; 595(4):1059-1076. PubMed ID: 27779763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of the cystic fibrosis transmembrane conductance regulator Cl
    Wang Y; Cai Z; Gosling M; Sheppard DN
    Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L846-L857. PubMed ID: 30136610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unified view of cystic fibrosis transmembrane conductance regulator (CFTR) gating: combining the allosterism of a ligand-gated channel with the enzymatic activity of an ATP-binding cassette (ABC) transporter.
    Kirk KL; Wang W
    J Biol Chem; 2011 Apr; 286(15):12813-9. PubMed ID: 21296873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.